AACR IO 2025: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherap

This new major conference will encompass the very best of basic, translational, and clinical research in immunology, inflammation and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. The cutting-edge AACR IO 2025 program will appeal to a wide audience of basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and lay press. A mix of keynote lectures, major symposia, spotlight sessions, educational sessions, special sessions, and poster sessions with exhibits will cover the spectrum of the IO field – including late-breaking clinical trials sessions highlighting new agents and IO combinations, and the results of practice-changing clinical trials. ABSTRACT CATEGORIES - Adaptive immunity in tumors - Adoptive cell therapy - Antibodies - Antigens - Car t - Cellular therapy - Combination immunotherapies - Cytokines - Endogenous antitumor immunity - Epigenetic regulation of tumor immunity - Immune checkpoints - Immune mechanisms - Immune monitoring - ...